Skip to main content
OpenTrials

Clinical trial condition

Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line

Explore clinical trials studying Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line trial results

Completed

Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer

NCT01611558

Conditions
Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line
Locations
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • AdventHealth Cancer Institute Orlando, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute. Atlanta, Georgia, United States
View all 17 locations
View Trial Details